C. Arslan And K. Altundag, "Increased mean corpuscular volume of erythrocytes predicts the response to metronomic cyclophosphamide, capecitabine and bevacizumab treatment: Is it true for capecitabine treatment or more?," BREAST , vol.21, no.4, pp.612-613, 2012
Arslan, C. And Altundag, K. 2012. Increased mean corpuscular volume of erythrocytes predicts the response to metronomic cyclophosphamide, capecitabine and bevacizumab treatment: Is it true for capecitabine treatment or more?. BREAST , vol.21, no.4 , 612-613.
Arslan, C., & Altundag, K., (2012). Increased mean corpuscular volume of erythrocytes predicts the response to metronomic cyclophosphamide, capecitabine and bevacizumab treatment: Is it true for capecitabine treatment or more?. BREAST , vol.21, no.4, 612-613.
Arslan, ÇAĞATAY, And Kadri Altundag. "Increased mean corpuscular volume of erythrocytes predicts the response to metronomic cyclophosphamide, capecitabine and bevacizumab treatment: Is it true for capecitabine treatment or more?," BREAST , vol.21, no.4, 612-613, 2012
Arslan, ÇAĞATAY And Altundag, Kadri. "Increased mean corpuscular volume of erythrocytes predicts the response to metronomic cyclophosphamide, capecitabine and bevacizumab treatment: Is it true for capecitabine treatment or more?." BREAST , vol.21, no.4, pp.612-613, 2012
Arslan, C. And Altundag, K. (2012) . "Increased mean corpuscular volume of erythrocytes predicts the response to metronomic cyclophosphamide, capecitabine and bevacizumab treatment: Is it true for capecitabine treatment or more?." BREAST , vol.21, no.4, pp.612-613.
@article{article, author={ÇAĞATAY ARSLAN And author={Kadri Altundag}, title={Increased mean corpuscular volume of erythrocytes predicts the response to metronomic cyclophosphamide, capecitabine and bevacizumab treatment: Is it true for capecitabine treatment or more?}, journal={BREAST}, year=2012, pages={612-613} }